Alimera Sciences | ALIM - Aktywa



Aktywa Zmiana Data
AbbVie USD 29.06B 523M 2025-12
Bayer EUR 32.91B 30M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12